VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 189 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.80 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $9,781,000 | -66.2% | 1,323,547 | -54.8% | 0.01% | -65.7% |
| Q3 2022 | $28,944,000 | -7.7% | 2,928,542 | +1.8% | 0.04% | 0.0% |
| Q2 2022 | $31,365,000 | -5.3% | 2,877,580 | -1.7% | 0.04% | +40.0% |
| Q1 2022 | $33,121,000 | -27.5% | 2,928,478 | +0.5% | 0.02% | -34.2% |
| Q4 2021 | $45,712,000 | -17.6% | 2,913,471 | -10.0% | 0.04% | -19.1% |
| Q3 2021 | $55,474,000 | -19.5% | 3,236,524 | +1.0% | 0.05% | -17.5% |
| Q2 2021 | $68,936,000 | +45.8% | 3,204,836 | +1.8% | 0.06% | -14.9% |
| Q1 2021 | $47,266,000 | +12.7% | 3,146,878 | -1.4% | 0.07% | +9.8% |
| Q4 2020 | $41,943,000 | +32.1% | 3,192,034 | -2.9% | 0.06% | +13.0% |
| Q3 2020 | $31,762,000 | -15.6% | 3,288,023 | -0.1% | 0.05% | -16.9% |
| Q2 2020 | $37,644,000 | +13.5% | 3,290,578 | +2.8% | 0.06% | -4.4% |
| Q1 2020 | $33,162,000 | -34.8% | 3,200,963 | +3.3% | 0.07% | -6.8% |
| Q4 2019 | $50,835,000 | +37.2% | 3,097,822 | +11.0% | 0.07% | +17.7% |
| Q3 2019 | $37,059,000 | -66.3% | 2,790,596 | -64.3% | 0.06% | -1.6% |
| Q2 2019 | $110,100,000 | +153.9% | 7,814,076 | +231.5% | 0.06% | -14.9% |
| Q1 2019 | $43,366,000 | -32.5% | 2,356,842 | -4.1% | 0.07% | -40.3% |
| Q4 2018 | $64,235,000 | +4.4% | 2,458,284 | -8.3% | 0.12% | +24.0% |
| Q3 2018 | $61,533,000 | +26.4% | 2,681,144 | +4.9% | 0.10% | +19.0% |
| Q2 2018 | $48,673,000 | +26.8% | 2,555,004 | +12.1% | 0.08% | +20.0% |
| Q1 2018 | $38,400,000 | +11.4% | 2,278,947 | +0.5% | 0.07% | +14.8% |
| Q4 2017 | $34,484,000 | +1.9% | 2,268,691 | +20.0% | 0.06% | 0.0% |
| Q3 2017 | $33,833,000 | +21.8% | 1,890,085 | +10.9% | 0.06% | +19.6% |
| Q2 2017 | $27,768,000 | +26.7% | 1,703,559 | +8.8% | 0.05% | +27.5% |
| Q1 2017 | $21,914,000 | +0.1% | 1,565,281 | +14.0% | 0.04% | -4.8% |
| Q4 2016 | $21,894,000 | +2.3% | 1,372,640 | +6.8% | 0.04% | +2.4% |
| Q3 2016 | $21,395,000 | -37.6% | 1,285,749 | -58.1% | 0.04% | +20.6% |
| Q2 2016 | $34,298,000 | +233.6% | 3,065,066 | +149.2% | 0.03% | +61.9% |
| Q1 2016 | $10,282,000 | +1.4% | 1,229,942 | +12.9% | 0.02% | 0.0% |
| Q4 2015 | $10,144,000 | -10.7% | 1,089,532 | +8.2% | 0.02% | -12.5% |
| Q3 2015 | $11,360,000 | +9.9% | 1,007,058 | +23.6% | 0.02% | +20.0% |
| Q2 2015 | $10,337,000 | +56.7% | 814,571 | +14.8% | 0.02% | +53.8% |
| Q1 2015 | $6,598,000 | +254.4% | 709,474 | +445.7% | 0.01% | +225.0% |
| Q4 2014 | $1,862,000 | +38.0% | 130,000 | 0.0% | 0.00% | +33.3% |
| Q3 2014 | $1,349,000 | -53.7% | 130,000 | -27.8% | 0.00% | -50.0% |
| Q2 2014 | $2,912,000 | -36.0% | 180,000 | -35.7% | 0.01% | -25.0% |
| Q1 2014 | $4,550,000 | +167.6% | 280,000 | +104.4% | 0.01% | +166.7% |
| Q4 2013 | $1,700,000 | – | 137,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,581,176 | $60,838,000 | 4.05% |
| ARMISTICE CAPITAL, LLC | 3,548,000 | $47,117,000 | 3.12% |
| Birchview Capital, LP | 80,000 | $1,062,000 | 0.71% |
| 361 CAPITAL LLC | 163,333 | $2,169,000 | 0.40% |
| CADENCE CAPITAL MANAGEMENT LLC | 172,512 | $2,291,000 | 0.32% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 215,936 | $2,868,000 | 0.25% |
| Zebra Capital Management LLC | 15,634 | $208,000 | 0.23% |
| BOOTHBAY FUND MANAGEMENT, LLC | 149,139 | $1,981,000 | 0.18% |
| GLOBEFLEX CAPITAL L P | 48,207 | $640,000 | 0.14% |
| Virtus ETF Advisers LLC | 47,470 | $630,000 | 0.13% |